#ID(s) interactor A	ID(s) interactor B	Alt. ID(s) interactor A	Alt. ID(s) interactor B	Alias(es) interactor A	Alias(es) interactor B	Interaction detection method(s)	Publication 1st author(s)	Publication Identifier(s)	Taxid interactor A	Taxid interactor B	Interaction type(s)	Source database(s)	Interaction identifier(s)	Confidence value(s)	Expansion method(s)	Biological role(s) interactor A	Biological role(s) interactor B	Experimental role(s) interactor A	Experimental role(s) interactor B	Type(s) interactor A	Type(s) interactor B	Xref(s) interactor A	Xref(s) interactor B	Interaction Xref(s)	Annotation(s) interactor A	Annotation(s) interactor B	Interaction annotation(s)	Host organism(s)	Interaction parameter(s)	Creation date	Update date	Checksum(s) interactor A	Checksum(s) interactor B	Interaction Checksum(s)	Negative	Feature(s) interactor A	Feature(s) interactor B	Stoichiometry(s) interactor A	Stoichiometry(s) interactor B	Identification method participant A	Identification method participant B
uniprotkb:A2NTU7	uniprotkb:A2NTY6	intact:EBI-1264825	intact:EBI-1264834	psi-mi:a2ntu7_mouse(display_long)	psi-mi:a2nty6_mouse(display_long)	psi-mi:"MI:0114"(x-ray crystallography)	Colf et al. (2007)	imex:IM-11949|pubmed:17418792	taxid:10090(mouse)|taxid:10090(Mus musculus)	taxid:10090(mouse)|taxid:10090(Mus musculus)	psi-mi:"MI:0915"(physical association)	psi-mi:"MI:0469"(IntAct)	intact:EBI-1264855|wwpdb:2e7l|imex:IM-11949-1	-	psi-mi:"MI:1060"(spoke expansion)	psi-mi:"MI:0499"(unspecified role)	psi-mi:"MI:0499"(unspecified role)	psi-mi:"MI:0497"(neutral component)	psi-mi:"MI:0497"(neutral component)	psi-mi:"MI:0326"(protein)	psi-mi:"MI:0326"(protein)	interpro:IPR015370(Protein of unknown function DUF1968)|interpro:IPR007110(Immunoglobulin-like)|interpro:IPR013783(Immunoglobulin-like fold)|interpro:IPR013106(Immunoglobulin V-set)|rcsb pdb:2E7L|interpro:IPR003599(Immunoglobulin subtype)|interpro:IPR036179	interpro:IPR007110(Immunoglobulin-like)|interpro:IPR013783(Immunoglobulin-like fold)|interpro:IPR013106(Immunoglobulin V-set)|rcsb pdb:2E7L|rcsb pdb:2ICW|rcsb pdb:6MIV|rcsb pdb:6MIY|rcsb pdb:6MJ4|rcsb pdb:6MJ6|rcsb pdb:6MJI|rcsb pdb:6MJJ|rcsb pdb:6MJQ|rcsb pdb:4Y16|rcsb pdb:4Y2D|rcsb pdb:4Y4F|rcsb pdb:4Y4H|rcsb pdb:6MJA|rcsb pdb:4Y4K|rcsb pdb:4ZAK|rcsb pdb:2OI9|rcsb pdb:2PXY|rcsb pdb:2Z31|rcsb pdb:2Z35|rcsb pdb:3E2H|interpro:IPR003599(Immunoglobulin subtype)|interpro:IPR036179	-	-	-	figure legend:Table S1.|3d-r-factors:working 22.4 percent, free 24.6 percent|3d-resolution:2.50 A|caution:"The protein H2-L had additional mutation F9Y (possibly F8 in UniProtKB entry) which increased solubility of the proteins. These residue posiiton however does not correspond with the UniProtKB entry."|comment:The cytotoxic T-cell receptor precursor described here has mutation in the linker V beta 8.2 region to increase solubility. The mutations described are gly17glu his47tyr iso75thr leu81ser|full coverage:Only protein-protein interactions|curation depth:imex curation	taxid:-1(in vitro)|taxid:-1(In vitro)	-	2007/06/18	2014/10/16	rogid:vvZYOWwFUcVYoRFIxIVBBCmcv6w10090	rogid:FORhmKAsmcedR1sFe2nfi6XrCK410090	intact-crc:3118833C93F8AE5F|rigid:0cXpj5bkqTy812tj9yyiNHxzZhw	false	binding-associated region:21-121	-	-	-	psi-mi:"MI:0396"(predetermined participant)	psi-mi:"MI:0396"(predetermined participant)
uniprotkb:A2NTU7	uniprotkb:P01897	intact:EBI-1264825	intact:EBI-1264841|uniprotkb:Q31195|uniprotkb:Q31196|uniprotkb:Q31197	psi-mi:a2ntu7_mouse(display_long)	psi-mi:ha1l_mouse(display_long)|uniprotkb:H2-L(gene name)|psi-mi:H2-L(display_short)	psi-mi:"MI:0114"(x-ray crystallography)	Colf et al. (2007)	imex:IM-11949|pubmed:17418792	taxid:10090(mouse)|taxid:10090(Mus musculus)	taxid:10090(mouse)|taxid:10090(Mus musculus)	psi-mi:"MI:0915"(physical association)	psi-mi:"MI:0469"(IntAct)	intact:EBI-1264855|wwpdb:2e7l|imex:IM-11949-1	-	psi-mi:"MI:1060"(spoke expansion)	psi-mi:"MI:0499"(unspecified role)	psi-mi:"MI:0499"(unspecified role)	psi-mi:"MI:0497"(neutral component)	psi-mi:"MI:0497"(neutral component)	psi-mi:"MI:0326"(protein)	psi-mi:"MI:0326"(protein)	interpro:IPR015370(Protein of unknown function DUF1968)|interpro:IPR007110(Immunoglobulin-like)|interpro:IPR013783(Immunoglobulin-like fold)|interpro:IPR013106(Immunoglobulin V-set)|rcsb pdb:2E7L|interpro:IPR003599(Immunoglobulin subtype)|interpro:IPR036179	interpro:IPR007110(Immunoglobulin-like)|interpro:IPR013783(Immunoglobulin-like fold)|interpro:IPR003006(Immunoglobulin/major histocompatibility complex, conserved site)|interpro:IPR003597(Immunoglobulin C1-set)|interpro:IPR011161(MHC class I-like antigen recognition)|interpro:IPR011162(MHC classes I and II-like antigen recognition)|interpro:IPR001039(MHC class I, alpha chain, alpha1 and alpha2)|interpro:IPR010579(MHC class I, alpha chain, C-terminal)|mint:P01897|interpro:IPR036179|interpro:IPR037055|go:"GO:0002474"(antigen processing and presentation of peptide antigen via MHC class I)|go:"GO:0002476"(antigen processing and presentation of endogenous peptide antigen via MHC class Ib)|go:"GO:0005615"(extracellular space)|go:"GO:0006952"(defense response)|go:"GO:0006955"(immune response)|go:"GO:0009897"(external side of plasma membrane)|go:"GO:0030670"(phagocytic vesicle membrane)|go:"GO:0042612"(MHC class I protein complex)|go:"GO:0071556"(integral component of lumenal side of endoplasmic reticulum membrane)|rcsb pdb:1LD9|rcsb pdb:1LDP|rcsb pdb:2E7L|rcsb pdb:2OI9|rcsb pdb:3E2H|rcsb pdb:3E3Q|rcsb pdb:3ERY|rcsb pdb:3TF7|rcsb pdb:3TFK|rcsb pdb:3TJH|rcsb pdb:3TPU|rcsb pdb:3UO1|rcsb pdb:3UYR|rcsb pdb:3V4U|rcsb pdb:3V52|rcsb pdb:3VJ6|rcsb pdb:4MS8|rcsb pdb:4MVB|rcsb pdb:4MXQ|rcsb pdb:4N0C|rcsb pdb:4N5E|rcsb pdb:4NHU|rcsb pdb:5VCL|rcsb pdb:6L9K|rcsb pdb:6L9L|rcsb pdb:6L9M|rcsb pdb:6L9N	-	-	-	figure legend:Table S1.|3d-r-factors:working 22.4 percent, free 24.6 percent|3d-resolution:2.50 A|caution:"The protein H2-L had additional mutation F9Y (possibly F8 in UniProtKB entry) which increased solubility of the proteins. These residue posiiton however does not correspond with the UniProtKB entry."|comment:The cytotoxic T-cell receptor precursor described here has mutation in the linker V beta 8.2 region to increase solubility. The mutations described are gly17glu his47tyr iso75thr leu81ser|full coverage:Only protein-protein interactions|curation depth:imex curation	taxid:-1(in vitro)|taxid:-1(In vitro)	-	2007/06/18	2014/10/16	rogid:vvZYOWwFUcVYoRFIxIVBBCmcv6w10090	rogid:I2yLZar7ZdKeujrDMbpD9T9HMbo10090	intact-crc:3118833C93F8AE5F|rigid:0cXpj5bkqTy812tj9yyiNHxzZhw	false	binding-associated region:21-121	mutation:47-47,36-36|binding-associated region:25-362	-	-	psi-mi:"MI:0396"(predetermined participant)	psi-mi:"MI:0396"(predetermined participant)
uniprotkb:A2NTU7	uniprotkb:Q6P8I7	intact:EBI-1264825	intact:EBI-1264863	psi-mi:a2ntu7_mouse(display_long)	psi-mi:q6p8i7_mouse(display_long)|uniprotkb:Ogdh(gene name)|psi-mi:Ogdh(display_short)	psi-mi:"MI:0114"(x-ray crystallography)	Colf et al. (2007)	imex:IM-11949|pubmed:17418792	taxid:10090(mouse)|taxid:10090(Mus musculus)	taxid:10090(mouse)|taxid:10090(Mus musculus)	psi-mi:"MI:0915"(physical association)	psi-mi:"MI:0469"(IntAct)	intact:EBI-1264855|wwpdb:2e7l|imex:IM-11949-1	-	psi-mi:"MI:1060"(spoke expansion)	psi-mi:"MI:0499"(unspecified role)	psi-mi:"MI:0499"(unspecified role)	psi-mi:"MI:0497"(neutral component)	psi-mi:"MI:0497"(neutral component)	psi-mi:"MI:0326"(protein)	psi-mi:"MI:0326"(protein)	interpro:IPR015370(Protein of unknown function DUF1968)|interpro:IPR007110(Immunoglobulin-like)|interpro:IPR013783(Immunoglobulin-like fold)|interpro:IPR013106(Immunoglobulin V-set)|rcsb pdb:2E7L|interpro:IPR003599(Immunoglobulin subtype)|interpro:IPR036179	interpro:IPR011603(2-oxoglutarate dehydrogenase, E1 component)|interpro:IPR031717|interpro:IPR042179|go:"GO:0004591"("oxoglutarate dehydrogenase (succinyl-transferring) activity")|go:"GO:0006099"(tricarboxylic acid cycle)|go:"GO:0030976"(thiamine pyrophosphate binding)	-	-	-	figure legend:Table S1.|3d-r-factors:working 22.4 percent, free 24.6 percent|3d-resolution:2.50 A|caution:"The protein H2-L had additional mutation F9Y (possibly F8 in UniProtKB entry) which increased solubility of the proteins. These residue posiiton however does not correspond with the UniProtKB entry."|comment:The cytotoxic T-cell receptor precursor described here has mutation in the linker V beta 8.2 region to increase solubility. The mutations described are gly17glu his47tyr iso75thr leu81ser|full coverage:Only protein-protein interactions|curation depth:imex curation	taxid:-1(in vitro)|taxid:-1(In vitro)	-	2007/06/18	2014/10/16	rogid:vvZYOWwFUcVYoRFIxIVBBCmcv6w10090	rogid:s0ADb4emOf287kcMP3XEEtYY2jQ10090	intact-crc:3118833C93F8AE5F|rigid:0cXpj5bkqTy812tj9yyiNHxzZhw	false	binding-associated region:21-121	binding-associated region:123-131|his tag:c-c	-	-	psi-mi:"MI:0396"(predetermined participant)	psi-mi:"MI:0396"(predetermined participant)
uniprotkb:A2NTU7	uniprotkb:A2NTY6	intact:EBI-1264825	intact:EBI-1264834	psi-mi:a2ntu7_mouse(display_long)	psi-mi:a2nty6_mouse(display_long)	psi-mi:"MI:0114"(x-ray crystallography)	Colf et al. (2007)	imex:IM-11949|pubmed:17418792	taxid:10090(mouse)|taxid:10090(Mus musculus)	taxid:10090(mouse)|taxid:10090(Mus musculus)	psi-mi:"MI:0915"(physical association)	psi-mi:"MI:0469"(IntAct)	intact:EBI-1264886|wwpdb:2oI9|imex:IM-11949-2	-	psi-mi:"MI:1060"(spoke expansion)	psi-mi:"MI:0499"(unspecified role)	psi-mi:"MI:0499"(unspecified role)	psi-mi:"MI:0497"(neutral component)	psi-mi:"MI:0497"(neutral component)	psi-mi:"MI:0326"(protein)	psi-mi:"MI:0326"(protein)	interpro:IPR015370(Protein of unknown function DUF1968)|interpro:IPR007110(Immunoglobulin-like)|interpro:IPR013783(Immunoglobulin-like fold)|interpro:IPR013106(Immunoglobulin V-set)|rcsb pdb:2E7L|interpro:IPR003599(Immunoglobulin subtype)|interpro:IPR036179	interpro:IPR007110(Immunoglobulin-like)|interpro:IPR013783(Immunoglobulin-like fold)|interpro:IPR013106(Immunoglobulin V-set)|rcsb pdb:2E7L|rcsb pdb:2ICW|rcsb pdb:6MIV|rcsb pdb:6MIY|rcsb pdb:6MJ4|rcsb pdb:6MJ6|rcsb pdb:6MJI|rcsb pdb:6MJJ|rcsb pdb:6MJQ|rcsb pdb:4Y16|rcsb pdb:4Y2D|rcsb pdb:4Y4F|rcsb pdb:4Y4H|rcsb pdb:6MJA|rcsb pdb:4Y4K|rcsb pdb:4ZAK|rcsb pdb:2OI9|rcsb pdb:2PXY|rcsb pdb:2Z31|rcsb pdb:2Z35|rcsb pdb:3E2H|interpro:IPR003599(Immunoglobulin subtype)|interpro:IPR036179	-	-	-	figure legend:Table S1. Fig S2, S3|3d-r-factors:working 22.0 percent, free 22.6 percent|3d-resolution:2.35 A|caution:"The protein H2-L had additional mutation F9Y (possibly UniProtKB entry residue F8) which increased solubility of the protein."|full coverage:Only protein-protein interactions|curation depth:imex curation	taxid:-1(in vitro)|taxid:-1(In vitro)	-	2007/06/18	2014/10/16	rogid:vvZYOWwFUcVYoRFIxIVBBCmcv6w10090	rogid:FORhmKAsmcedR1sFe2nfi6XrCK410090	intact-crc:0702ADA5E38B38DD|rigid:0cXpj5bkqTy812tj9yyiNHxzZhw	false	-	-	-	-	psi-mi:"MI:0396"(predetermined participant)	psi-mi:"MI:0396"(predetermined participant)
uniprotkb:A2NTU7	uniprotkb:P01897	intact:EBI-1264825	intact:EBI-1264841|uniprotkb:Q31195|uniprotkb:Q31196|uniprotkb:Q31197	psi-mi:a2ntu7_mouse(display_long)	psi-mi:ha1l_mouse(display_long)|uniprotkb:H2-L(gene name)|psi-mi:H2-L(display_short)	psi-mi:"MI:0114"(x-ray crystallography)	Colf et al. (2007)	imex:IM-11949|pubmed:17418792	taxid:10090(mouse)|taxid:10090(Mus musculus)	taxid:10090(mouse)|taxid:10090(Mus musculus)	psi-mi:"MI:0915"(physical association)	psi-mi:"MI:0469"(IntAct)	intact:EBI-1264886|wwpdb:2oI9|imex:IM-11949-2	-	psi-mi:"MI:1060"(spoke expansion)	psi-mi:"MI:0499"(unspecified role)	psi-mi:"MI:0499"(unspecified role)	psi-mi:"MI:0497"(neutral component)	psi-mi:"MI:0497"(neutral component)	psi-mi:"MI:0326"(protein)	psi-mi:"MI:0326"(protein)	interpro:IPR015370(Protein of unknown function DUF1968)|interpro:IPR007110(Immunoglobulin-like)|interpro:IPR013783(Immunoglobulin-like fold)|interpro:IPR013106(Immunoglobulin V-set)|rcsb pdb:2E7L|interpro:IPR003599(Immunoglobulin subtype)|interpro:IPR036179	interpro:IPR007110(Immunoglobulin-like)|interpro:IPR013783(Immunoglobulin-like fold)|interpro:IPR003006(Immunoglobulin/major histocompatibility complex, conserved site)|interpro:IPR003597(Immunoglobulin C1-set)|interpro:IPR011161(MHC class I-like antigen recognition)|interpro:IPR011162(MHC classes I and II-like antigen recognition)|interpro:IPR001039(MHC class I, alpha chain, alpha1 and alpha2)|interpro:IPR010579(MHC class I, alpha chain, C-terminal)|mint:P01897|interpro:IPR036179|interpro:IPR037055|go:"GO:0002474"(antigen processing and presentation of peptide antigen via MHC class I)|go:"GO:0002476"(antigen processing and presentation of endogenous peptide antigen via MHC class Ib)|go:"GO:0005615"(extracellular space)|go:"GO:0006952"(defense response)|go:"GO:0006955"(immune response)|go:"GO:0009897"(external side of plasma membrane)|go:"GO:0030670"(phagocytic vesicle membrane)|go:"GO:0042612"(MHC class I protein complex)|go:"GO:0071556"(integral component of lumenal side of endoplasmic reticulum membrane)|rcsb pdb:1LD9|rcsb pdb:1LDP|rcsb pdb:2E7L|rcsb pdb:2OI9|rcsb pdb:3E2H|rcsb pdb:3E3Q|rcsb pdb:3ERY|rcsb pdb:3TF7|rcsb pdb:3TFK|rcsb pdb:3TJH|rcsb pdb:3TPU|rcsb pdb:3UO1|rcsb pdb:3UYR|rcsb pdb:3V4U|rcsb pdb:3V52|rcsb pdb:3VJ6|rcsb pdb:4MS8|rcsb pdb:4MVB|rcsb pdb:4MXQ|rcsb pdb:4N0C|rcsb pdb:4N5E|rcsb pdb:4NHU|rcsb pdb:5VCL|rcsb pdb:6L9K|rcsb pdb:6L9L|rcsb pdb:6L9M|rcsb pdb:6L9N	-	-	-	figure legend:Table S1. Fig S2, S3|3d-r-factors:working 22.0 percent, free 22.6 percent|3d-resolution:2.35 A|caution:"The protein H2-L had additional mutation F9Y (possibly UniProtKB entry residue F8) which increased solubility of the protein."|full coverage:Only protein-protein interactions|curation depth:imex curation	taxid:-1(in vitro)|taxid:-1(In vitro)	-	2007/06/18	2014/10/16	rogid:vvZYOWwFUcVYoRFIxIVBBCmcv6w10090	rogid:I2yLZar7ZdKeujrDMbpD9T9HMbo10090	intact-crc:0702ADA5E38B38DD|rigid:0cXpj5bkqTy812tj9yyiNHxzZhw	false	-	mutation:36-36,47-47|binding-associated region:25-362	-	-	psi-mi:"MI:0396"(predetermined participant)	psi-mi:"MI:0396"(predetermined participant)
uniprotkb:A2NTU7	uniprotkb:Q6P8I7	intact:EBI-1264825	intact:EBI-1264863	psi-mi:a2ntu7_mouse(display_long)	psi-mi:q6p8i7_mouse(display_long)|uniprotkb:Ogdh(gene name)|psi-mi:Ogdh(display_short)	psi-mi:"MI:0114"(x-ray crystallography)	Colf et al. (2007)	imex:IM-11949|pubmed:17418792	taxid:10090(mouse)|taxid:10090(Mus musculus)	taxid:10090(mouse)|taxid:10090(Mus musculus)	psi-mi:"MI:0915"(physical association)	psi-mi:"MI:0469"(IntAct)	intact:EBI-1264886|wwpdb:2oI9|imex:IM-11949-2	-	psi-mi:"MI:1060"(spoke expansion)	psi-mi:"MI:0499"(unspecified role)	psi-mi:"MI:0499"(unspecified role)	psi-mi:"MI:0497"(neutral component)	psi-mi:"MI:0497"(neutral component)	psi-mi:"MI:0326"(protein)	psi-mi:"MI:0326"(protein)	interpro:IPR015370(Protein of unknown function DUF1968)|interpro:IPR007110(Immunoglobulin-like)|interpro:IPR013783(Immunoglobulin-like fold)|interpro:IPR013106(Immunoglobulin V-set)|rcsb pdb:2E7L|interpro:IPR003599(Immunoglobulin subtype)|interpro:IPR036179	interpro:IPR011603(2-oxoglutarate dehydrogenase, E1 component)|interpro:IPR031717|interpro:IPR042179|go:"GO:0004591"("oxoglutarate dehydrogenase (succinyl-transferring) activity")|go:"GO:0006099"(tricarboxylic acid cycle)|go:"GO:0030976"(thiamine pyrophosphate binding)	-	-	-	figure legend:Table S1. Fig S2, S3|3d-r-factors:working 22.0 percent, free 22.6 percent|3d-resolution:2.35 A|caution:"The protein H2-L had additional mutation F9Y (possibly UniProtKB entry residue F8) which increased solubility of the protein."|full coverage:Only protein-protein interactions|curation depth:imex curation	taxid:-1(in vitro)|taxid:-1(In vitro)	-	2007/06/18	2014/10/16	rogid:vvZYOWwFUcVYoRFIxIVBBCmcv6w10090	rogid:s0ADb4emOf287kcMP3XEEtYY2jQ10090	intact-crc:0702ADA5E38B38DD|rigid:0cXpj5bkqTy812tj9yyiNHxzZhw	false	-	binding-associated region:123-131	-	-	psi-mi:"MI:0396"(predetermined participant)	psi-mi:"MI:0396"(predetermined participant)
uniprotkb:A2NTU7	uniprotkb:A2NTY6	intact:EBI-1264825	intact:EBI-1264834	psi-mi:a2ntu7_mouse(display_long)	psi-mi:a2nty6_mouse(display_long)	psi-mi:"MI:0065"(isothermal titration calorimetry)	Colf et al. (2007)	imex:IM-11949|pubmed:17418792	taxid:10090(mouse)|taxid:10090(Mus musculus)	taxid:10090(mouse)|taxid:10090(Mus musculus)	psi-mi:"MI:0915"(physical association)	psi-mi:"MI:0469"(IntAct)	intact:EBI-1265197|imex:IM-11949-3	-	psi-mi:"MI:1060"(spoke expansion)	psi-mi:"MI:0499"(unspecified role)	psi-mi:"MI:0499"(unspecified role)	psi-mi:"MI:0497"(neutral component)	psi-mi:"MI:0497"(neutral component)	psi-mi:"MI:0326"(protein)	psi-mi:"MI:0326"(protein)	interpro:IPR015370(Protein of unknown function DUF1968)|interpro:IPR007110(Immunoglobulin-like)|interpro:IPR013783(Immunoglobulin-like fold)|interpro:IPR013106(Immunoglobulin V-set)|rcsb pdb:2E7L|interpro:IPR003599(Immunoglobulin subtype)|interpro:IPR036179	interpro:IPR007110(Immunoglobulin-like)|interpro:IPR013783(Immunoglobulin-like fold)|interpro:IPR013106(Immunoglobulin V-set)|rcsb pdb:2E7L|rcsb pdb:2ICW|rcsb pdb:6MIV|rcsb pdb:6MIY|rcsb pdb:6MJ4|rcsb pdb:6MJ6|rcsb pdb:6MJI|rcsb pdb:6MJJ|rcsb pdb:6MJQ|rcsb pdb:4Y16|rcsb pdb:4Y2D|rcsb pdb:4Y4F|rcsb pdb:4Y4H|rcsb pdb:6MJA|rcsb pdb:4Y4K|rcsb pdb:4ZAK|rcsb pdb:2OI9|rcsb pdb:2PXY|rcsb pdb:2Z31|rcsb pdb:2Z35|rcsb pdb:3E2H|interpro:IPR003599(Immunoglobulin subtype)|interpro:IPR036179	psi-mi:"MI:0469"(intact)	-	-	figure legend:figure 5B.|caution:The protein H2-L had additional mutation F9Y which increased solubility of the proteins. These residue position however do not correspond to the UniProtKB entry.|comment:The Cytotoxic Tcell receptor precursor described here has mutation in the linker V beta 8.2 region to increase solubility. The mutations described are gly17glu his47tyr iso75thr leu81ser|kinetics:TCR with the gly17glu his47tyr iso75thr leu81ser mutations shows a Kd of 0.029 micromoles.|full coverage:Only protein-protein interactions|curation depth:imex curation	taxid:-1(in vitro)|taxid:-1(In vitro)	-	2007/06/18	2014/10/16	rogid:vvZYOWwFUcVYoRFIxIVBBCmcv6w10090	rogid:FORhmKAsmcedR1sFe2nfi6XrCK410090	intact-crc:E83FABDE9863E915|rigid:0cXpj5bkqTy812tj9yyiNHxzZhw	false	binding-associated region:21-121	-	-	-	psi-mi:"MI:0396"(predetermined participant)	psi-mi:"MI:0396"(predetermined participant)
uniprotkb:A2NTU7	uniprotkb:P01897	intact:EBI-1264825	intact:EBI-1264841|uniprotkb:Q31195|uniprotkb:Q31196|uniprotkb:Q31197	psi-mi:a2ntu7_mouse(display_long)	psi-mi:ha1l_mouse(display_long)|uniprotkb:H2-L(gene name)|psi-mi:H2-L(display_short)	psi-mi:"MI:0065"(isothermal titration calorimetry)	Colf et al. (2007)	imex:IM-11949|pubmed:17418792	taxid:10090(mouse)|taxid:10090(Mus musculus)	taxid:10090(mouse)|taxid:10090(Mus musculus)	psi-mi:"MI:0915"(physical association)	psi-mi:"MI:0469"(IntAct)	intact:EBI-1265197|imex:IM-11949-3	-	psi-mi:"MI:1060"(spoke expansion)	psi-mi:"MI:0499"(unspecified role)	psi-mi:"MI:0499"(unspecified role)	psi-mi:"MI:0497"(neutral component)	psi-mi:"MI:0497"(neutral component)	psi-mi:"MI:0326"(protein)	psi-mi:"MI:0326"(protein)	interpro:IPR015370(Protein of unknown function DUF1968)|interpro:IPR007110(Immunoglobulin-like)|interpro:IPR013783(Immunoglobulin-like fold)|interpro:IPR013106(Immunoglobulin V-set)|rcsb pdb:2E7L|interpro:IPR003599(Immunoglobulin subtype)|interpro:IPR036179	interpro:IPR007110(Immunoglobulin-like)|interpro:IPR013783(Immunoglobulin-like fold)|interpro:IPR003006(Immunoglobulin/major histocompatibility complex, conserved site)|interpro:IPR003597(Immunoglobulin C1-set)|interpro:IPR011161(MHC class I-like antigen recognition)|interpro:IPR011162(MHC classes I and II-like antigen recognition)|interpro:IPR001039(MHC class I, alpha chain, alpha1 and alpha2)|interpro:IPR010579(MHC class I, alpha chain, C-terminal)|mint:P01897|interpro:IPR036179|interpro:IPR037055|go:"GO:0002474"(antigen processing and presentation of peptide antigen via MHC class I)|go:"GO:0002476"(antigen processing and presentation of endogenous peptide antigen via MHC class Ib)|go:"GO:0005615"(extracellular space)|go:"GO:0006952"(defense response)|go:"GO:0006955"(immune response)|go:"GO:0009897"(external side of plasma membrane)|go:"GO:0030670"(phagocytic vesicle membrane)|go:"GO:0042612"(MHC class I protein complex)|go:"GO:0071556"(integral component of lumenal side of endoplasmic reticulum membrane)|rcsb pdb:1LD9|rcsb pdb:1LDP|rcsb pdb:2E7L|rcsb pdb:2OI9|rcsb pdb:3E2H|rcsb pdb:3E3Q|rcsb pdb:3ERY|rcsb pdb:3TF7|rcsb pdb:3TFK|rcsb pdb:3TJH|rcsb pdb:3TPU|rcsb pdb:3UO1|rcsb pdb:3UYR|rcsb pdb:3V4U|rcsb pdb:3V52|rcsb pdb:3VJ6|rcsb pdb:4MS8|rcsb pdb:4MVB|rcsb pdb:4MXQ|rcsb pdb:4N0C|rcsb pdb:4N5E|rcsb pdb:4NHU|rcsb pdb:5VCL|rcsb pdb:6L9K|rcsb pdb:6L9L|rcsb pdb:6L9M|rcsb pdb:6L9N	psi-mi:"MI:0469"(intact)	-	-	figure legend:figure 5B.|caution:The protein H2-L had additional mutation F9Y which increased solubility of the proteins. These residue position however do not correspond to the UniProtKB entry.|comment:The Cytotoxic Tcell receptor precursor described here has mutation in the linker V beta 8.2 region to increase solubility. The mutations described are gly17glu his47tyr iso75thr leu81ser|kinetics:TCR with the gly17glu his47tyr iso75thr leu81ser mutations shows a Kd of 0.029 micromoles.|full coverage:Only protein-protein interactions|curation depth:imex curation	taxid:-1(in vitro)|taxid:-1(In vitro)	-	2007/06/18	2014/10/16	rogid:vvZYOWwFUcVYoRFIxIVBBCmcv6w10090	rogid:I2yLZar7ZdKeujrDMbpD9T9HMbo10090	intact-crc:E83FABDE9863E915|rigid:0cXpj5bkqTy812tj9yyiNHxzZhw	false	binding-associated region:21-121	binding-associated region:25-362|mutation:36-36,47-47	-	-	psi-mi:"MI:0396"(predetermined participant)	psi-mi:"MI:0396"(predetermined participant)
uniprotkb:A2NTU7	uniprotkb:Q6P8I7	intact:EBI-1264825	intact:EBI-1264863	psi-mi:a2ntu7_mouse(display_long)	psi-mi:q6p8i7_mouse(display_long)|uniprotkb:Ogdh(gene name)|psi-mi:Ogdh(display_short)	psi-mi:"MI:0065"(isothermal titration calorimetry)	Colf et al. (2007)	imex:IM-11949|pubmed:17418792	taxid:10090(mouse)|taxid:10090(Mus musculus)	taxid:10090(mouse)|taxid:10090(Mus musculus)	psi-mi:"MI:0915"(physical association)	psi-mi:"MI:0469"(IntAct)	intact:EBI-1265197|imex:IM-11949-3	-	psi-mi:"MI:1060"(spoke expansion)	psi-mi:"MI:0499"(unspecified role)	psi-mi:"MI:0499"(unspecified role)	psi-mi:"MI:0497"(neutral component)	psi-mi:"MI:0497"(neutral component)	psi-mi:"MI:0326"(protein)	psi-mi:"MI:0326"(protein)	interpro:IPR015370(Protein of unknown function DUF1968)|interpro:IPR007110(Immunoglobulin-like)|interpro:IPR013783(Immunoglobulin-like fold)|interpro:IPR013106(Immunoglobulin V-set)|rcsb pdb:2E7L|interpro:IPR003599(Immunoglobulin subtype)|interpro:IPR036179	interpro:IPR011603(2-oxoglutarate dehydrogenase, E1 component)|interpro:IPR031717|interpro:IPR042179|go:"GO:0004591"("oxoglutarate dehydrogenase (succinyl-transferring) activity")|go:"GO:0006099"(tricarboxylic acid cycle)|go:"GO:0030976"(thiamine pyrophosphate binding)	psi-mi:"MI:0469"(intact)	-	-	figure legend:figure 5B.|caution:The protein H2-L had additional mutation F9Y which increased solubility of the proteins. These residue position however do not correspond to the UniProtKB entry.|comment:The Cytotoxic Tcell receptor precursor described here has mutation in the linker V beta 8.2 region to increase solubility. The mutations described are gly17glu his47tyr iso75thr leu81ser|kinetics:TCR with the gly17glu his47tyr iso75thr leu81ser mutations shows a Kd of 0.029 micromoles.|full coverage:Only protein-protein interactions|curation depth:imex curation	taxid:-1(in vitro)|taxid:-1(In vitro)	-	2007/06/18	2014/10/16	rogid:vvZYOWwFUcVYoRFIxIVBBCmcv6w10090	rogid:s0ADb4emOf287kcMP3XEEtYY2jQ10090	intact-crc:E83FABDE9863E915|rigid:0cXpj5bkqTy812tj9yyiNHxzZhw	false	binding-associated region:21-121	binding-associated region:123-131|his tag:c-c	-	-	psi-mi:"MI:0396"(predetermined participant)	psi-mi:"MI:0396"(predetermined participant)